A detailed history of Essex Investment Management CO LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Essex Investment Management CO LLC holds 69,148 shares of LGND stock, worth $7.87 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
69,148
Previous 70,780 2.31%
Holding current value
$7.87 Million
Previous $5.96 Million 16.15%
% of portfolio
1.29%
Previous 1.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$82.7 - $110.11 $134,966 - $179,699
-1,632 Reduced 2.31%
69,148 $6.93 Million
Q2 2024

Aug 12, 2024

BUY
$68.53 - $87.91 $4.85 Million - $6.22 Million
70,780 New
70,780 $5.96 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.92B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.